Staidson Mutual Funds | StatInvestor

Health Care & Life Sciences » Biotechnology | Staidson

Staidson | Mutual Funds

Mutual Funds that own Staidson

Name

Shares Held

% Shares Out

Change In Shares

% of Assets

As of Date

831,342

0.18%

92,780

4.49%

12/31/2017

Vanguard Emerging Markets Stock Index Fund

831,119

0.18%

07/31/2018

350,800

0.08%

350,800

0.86%

12/31/2017

273,335

0.06%

-33,400

0.71%

12/31/2017

116,488

0.03%

-28,800

0.7%

12/31/2017

60,500

0.01%

60,500

1.03%

12/31/2017

34,900

0.01%

-72,600

0.23%

12/31/2017

9,500

0.12%

12/31/2017

8,200

0.02%

12/31/2017

7,900

0.15%

12/31/2017

About Staidson

View Profile

Address	36 Jinghai 2nd Road Beijing Beijing 100176 China
Employees	-
Website	http://www.staidson.com
Updated	07/08/2019
Staidson (Beijing) Biopharmaceuticals Co., Ltd. engages in the research, development, production, and sale of independent intellectual property innovation drugs. Its products include mouse nerve growth factor injection, intravenous compound polyethylene glycol electrolyte powder solution, gliclazide, nabumetone, and aspirin. The company was founded on August 16, 2002 and is headquartered in Beijing, China.